文献速递主动脉疾病

市售与定制开窗分支器械治疗复杂主动脉瘤的比较

Comparison of commercially available versus customized branched-fenestrated devices in the treatment of complex aortic aneurysms.
PubMed 文献 · J Vasc Surg · 2018-08-17

2012年7月至2015年7月在北卡罗来纳大学教堂山分校回顾性分析131例复杂主动脉瘤修复(60例ZFEN,71例PSIDE),两组早期结局相似,但PSIDE住院时间显著更长(4.4天 vs 3.3天,P=0.05),结论认为更先进的开窗分支修复似乎不增加并发症,但需进一步研究长期结局。

要点

  • PSIDE组既往主动脉手术史更常见(33% vs 5%,P=0.0001),支架血管数更多(3.4 vs 2.2,P<0.001)。
  • 两组手术时间、估计失血量、透视时间无差异。
  • PSIDE组住院时间显著更长(4.4天 vs 3.3天,P=0.05),其余早期结局相似。

核心结论

  • 在有经验的治疗中心,更先进的开窗分支血管内修复与ZFEN器械相比似乎不增加修复相关并发症。
  • 虽然两组死亡率和发病率相当,但需要进一步研究评估长期结局。

研究设计与样本

  • 回顾性分析2012年7月至2015年7月在北卡罗来纳大学教堂山分校接受复杂主动脉瘤修复的患者,数据来自前瞻性收集的电子主动脉数据库。
  • 共131例修复(近肾或胸腹主动脉瘤),分为ZFEN组60例和PSIDE组71例(包括定制器械和p-branch)。
  • 分析人口学数据、心脏危险因素、合并症、CT血管造影解剖测量、手术数据和30天结局。

主要发现

  • PSIDE组既往主动脉手术史更常见(33% vs 5% [ZFEN];P=0.0001)。
  • PSIDE组支架血管数更多(3.4 vs 2.2;P<0.001),主动脉覆盖长度更长(72 mm vs -13.4 mm)。
  • 两组手术时间、估计失血量或透视时间无差异。
  • 除住院时间外,两组早期结局相似;PSIDE组住院时间显著更长(4.4天 vs 3.3天;P=0.05)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate and compare the early outcomes of patients treated for complex aortic aneurysms using a commercially available Zenith fenestrated endograft (ZFEN) or an advanced customized fenestrated-branched endovascular repair, which includes custom-made device or off-the-shelf p-branch devices available for use in a physician-sponsored investigational device exemption (PSIDE). METHODS: Between July 2012 and July 2015, patients who underwent to complex aortic aneurysms repair at University of North Carolina-Chapel Hill were retrospectively analyzed using data prospectively collected in electronically maintained aortic database. Patients were separated in two groups: ZFEN and PSIDE (custom-made device and p-branch). Demographics data, cardiac risk factors, comorbidities, computed tomography angiography anatomic measurements (aneurysm diameter, length of aortic coverage above the celiac artery), procedural data (operative time, estimated blood loss, intraoperative complications), and 30-day outcomes (mortality, major adverse cardiac events, stroke/transient ischemic attack, paraplegia, gastrointestinal complications, visceral branch complications, and endoleak) were analyzed. RESULTS: Among the 131 repairs for complex aortic aneurysms (juxtarenal or thoracoabdominal), there were 60 ZFEN and 71 PSIDE devices. Demographics and risk factors had similar distribution between groups, except that PSIDE patients more commonly had a history of previous aortic surgery (33% vs 5% [ZFEN]; P = .0001). PSIDE patients had a greater number of stented vessels (3.4 vs 2.2; P < .001) and length of aortic coverage (72 mm vs -13.4 mm) than ZFEN; however, no differences were seen in operative time, estimated blood loss or fluoroscopic time. Early outcomes were similar between groups, except for duration of hospital stay, which was significantly longer in PSIDE cohort (4.4 days vs 3.3 days; P = .05). CONCLUSIONS: More advanced fenestrated-branched endovascular repair does not seem to increase the complications associated with repair compared with patients receiving a ZFEN device in an experienced treatment center. Although mortality and morbidity were comparable between the groups, further studies evaluating long-term outcomes are needed.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Motta F, Vallabhaneni R, Kalbaugh CA, et al. Comparison of commercially available versus customized branched-fenestrated devices in the treatment of complex aortic aneurysms. J Vasc Surg. 2018. PMID: 30126783. doi:10.1016/j.jvs.2018.05.215

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。